East Region Formulary
NHS Scotland

Medicine Categories

Browse formulary recommendations using the legacy BNF medicine categories

1. Gastro-intestinal system
  1. 1.1.0 Dyspepsia and gastro-oesophageal reflux disease
    1. 1.1.1 Antacids and simeticone
    2. 1.1.2 Compound alginates and proprietary indigestion preparations
  2. 1.2.0 Antispasmodics and other drugs altering gut motility
  3. 1.3.0 Antisecretory drugs and mucosal protectants
    1. 1.3.1 H2-receptor antagonists
    2. 1.3.2 Selective antimuscarinics
    3. 1.3.3 Chelates and complexes
    4. 1.3.4 Prostaglandin analogues
    5. 1.3.5 Proton pump inhibitors
  4. 1.4.0 Acute diarrhoea
    1. 1.4.1 Adsorbents and bulk-forming drugs
    2. 1.4.2 Antimotility drugs
    3. 1.4.3 Enkephalinase inhibitors
  5. 1.5.0 Chronic bowel disorders
    1. 1.5.1 Aminosalicylates
    2. 1.5.2 Corticosteroids
    3. 1.5.3 Drugs affecting the immune response
    4. 1.5.4 Food allergy
  6. 1.6.0 Laxatives
    1. 1.6.1 Bulk-forming laxatives
    2. 1.6.2 Stimulant laxatives
    3. 1.6.3 Faecal softeners
    4. 1.6.4 Osmotic laxatives
    5. 1.6.5 Bowel cleansing preparations
    6. 1.6.6 Peripheral opioid-receptor antagonists
    7. 1.6.7 Other drugs used in constipation
  7. 1.7.0 Local preparations for anal and rectal disorders
    1. 1.7.1 Soothing haemorrhoidal preparations
    2. 1.7.2 Compound haemorrhoidal preparations with corticosteroids
    3. 1.7.3 Rectal sclerosants
    4. 1.7.4 Management of anal fissures
  8. 1.8.0 Stoma care
  9. 1.9.0 Drugs affecting intestinal secretions
    1. 1.9.1 Drugs affecting biliary composition and flow
    2. 1.9.2 Bile acid sequestrants
    3. 1.9.3 Aprotinin
    4. 1.9.4 Pancreatin
2. Cardiovascular system
  1. 2.1.0 Positive inotropic drugs
    1. 2.1.1 Cardiac glycosides
    2. 2.1.2 Phosphodiesterase type-3 inhibitors
  2. 2.2.0 Diuretics
    1. 2.2.1 Thiazides and related diuretics
    2. 2.2.2 Loop diuretics
    3. 2.2.3 Potassium-sparing diuretics and aldosterone antagonists
    4. 2.2.4 Potassium-sparing diuretics with other diuretics
    5. 2.2.5 Osmotic diuretics
    6. 2.2.6 Mercurial diuretics
    7. 2.2.7 Carbonic anhydrase inhibitors
    8. 2.2.8 Diuretics with potassium
  3. 2.3.0 Anti-arrhythmic drugs
    1. 2.3.1 Management of arrhythmias
    2. 2.3.2 Drugs for arrhythmias
  4. 2.4.0 Beta-adrenoceptor blocking drugs
  5. 2.5.0 Hypertension and heart failure
    1. 2.5.1 Vasodilator antihypertensive drugs
    2. 2.5.2 Centrally acting antihypertensive drugs
    3. 2.5.3 Adrenergic neurone blocking drugs
    4. 2.5.4 Alpha-adrenoceptor blocking drugs
    5. 2.5.5 Drugs affecting the renin-angiotensin system
  6. 2.6.0 Nitrates, calcium-channel blockers, and other antianginal drugs
    1. 2.6.1 Nitrates
    2. 2.6.2 Calcium-channel blockers
    3. 2.6.3 Other antianginal drugs
    4. 2.6.4 Peripheral vasodilators and related drugs
  7. 2.7.0 Sympathomimetics
    1. 2.7.1 Inotropic sympathomimetics
    2. 2.7.2 Vasoconstrictor sympathomimetics
    3. 2.7.3 Cardiopulmonary resuscitation
  8. 2.8.0 Anticoagulants and protamine
    1. 2.8.1 Parenteral anticoagulants
    2. 2.8.2 Oral anticoagulants
    3. 2.8.3 Protamine sulfate
    4. 2.8.4 Idarucizumab
  9. 2.9.0 Antiplatelet drugs
  10. 2.10.0 Stable angina, acute coronary syndromes, and fibrinolysis
    1. 2.10.1 Management of stable angina and acute coronary syndromes
    2. 2.10.2 Fibrinolytic drugs
  11. 2.11.0 Antifibrinolytic drugs and haemostatics
  12. 2.12.0 Lipid-regulating drugs
  13. 2.13.0 Local sclerosants
3. Respiratory system
  1. 3.1.0 Bronchodilators
    1. 3.1.1 Adrenoceptor agonists
    2. 3.1.2 Antimuscarinic bronchodilators
    3. 3.1.3 Theophylline
    4. 3.1.4 Compound bronchodilator preparations
    5. 3.1.5 Peak flow meters, inhaler devices and nebulisers
  2. 3.2.0 Corticosteroids
  3. 3.3.0 Cromoglicate and related therapy, leukotriene receptor antagonists, and phosphodiesterase type-4 inhibitors
    1. 3.3.1 Cromoglicate and related therapy
    2. 3.3.2 Leukotriene receptor antagonists
    3. 3.3.3 Phosphodiesterase type-4 inhibitors
  4. 3.4.0 Antihistamines, hyposensitisation, and allergic emergencies
    1. 3.4.1 Antihistamines
    2. 3.4.2 Allergen immunotherapy
    3. 3.4.3 Allergic emergencies
  5. 3.5.0 Respiratory stimulants and pulmonary surfactants
    1. 3.5.1 Respiratory stimulants
    2. 3.5.2 Pulmonary surfactants
  6. 3.6.0 Oxygen
  7. 3.7.0 Mucolytics
  8. 3.8.0 Aromatic inhalations
  9. 3.9.0 Cough preparations
    1. 3.9.1 Cough suppressants
    2. 3.9.2 Demulcent and expectorant cough preparations
  10. 3.10.0 Systemic nasal decongestants
  11. 3.11.0 Antifibrotics
4. Central nervous system
  1. 4.1.0 Hypnotics and anxiolytics
    1. 4.1.1 Hypnotics
    2. 4.1.2 Anxiolytics
    3. 4.1.3 Barbiturates
  2. 4.2.0 Drugs used in psychoses and related disorders
    1. 4.2.1 Antipsychotic drugs
    2. 4.2.2 Antipsychotic depot injections
    3. 4.2.3 Drugs used for mania and hypomania
  3. 4.3.0 Antidepressant drugs
    1. 4.3.1 Tricyclic and related antidepressant drugs
    2. 4.3.2 Monoamine-oxidase inhibitors
    3. 4.3.3 Selective serotonin re-uptake inhibitors
    4. 4.3.4 Other antidepressant drugs
  4. 4.4.0 CNS stimulants and drugs used for attention deficit hyperactivity disorder
  5. 4.5.0 Obesity
    1. 4.5.1 Anti-obesity drugs acting on the gastro-intestinal tract
    2. 4.5.2 Centrally acting appetite suppressants
  6. 4.6.0 Drugs used in nausea and vertigo
  7. 4.7.0 Analgesics
    1. 4.7.1 Non-opioid analgesics and compound analgesic preparations
    2. 4.7.2 Opioid analgesics
    3. 4.7.3 Neuropathic pain
    4. 4.7.4 Antimigraine drugs
  8. 4.8.0 Antiepileptic drugs
    1. 4.8.1 Control of the epilepsies
    2. 4.8.2 Drugs used in status epilepticus
    3. 4.8.3 Febrile convulsions
  9. 4.9.0 Drugs used in parkinsonism and related disorders
    1. 4.9.1 Dopaminergic drugs used in Parkinson's disease
    2. 4.9.2 Antimuscarinic drugs used in parkinsonism
    3. 4.9.3 Drugs used in essential tremor, chorea, tics, and related disorders
  10. 4.10.0 Drugs used in substance dependence
    1. 4.10.1 Alcohol dependence
    2. 4.10.2 Nicotine dependence
    3. 4.10.3 Opioid dependence
  11. 4.11.0 Dementia
5. Infections
  1. 5.1.0 Antibacterial drugs
    1. 5.1.1 Penicillins
    2. 5.1.2 Cephalosporins, carbapenems, and other beta-lactams
    3. 5.1.3 Tetracyclines
    4. 5.1.4 Aminoglycosides
    5. 5.1.5 Macrolides
    6. 5.1.6 Clindamycin
    7. 5.1.7 Some other antibacterials
    8. 5.1.8 Sulfonamides and trimethoprim
    9. 5.1.9 Antituberculosis drugs
    10. 5.1.10 Antileprotic drugs
    11. 5.1.11 Metronidazole and tinidazole
    12. 5.1.12 Quinolones
    13. 5.1.13 Urinary-tract infections
  2. 5.2.0 Antifungal drugs
    1. 5.2.1 Triazole antifungals
    2. 5.2.2 Imidazole antifungals
    3. 5.2.3 Polyene antifungals
    4. 5.2.4 Echinocandin antifungals
    5. 5.2.5 Other antifungals
  3. 5.3.0 Antiviral drugs
    1. 5.3.1 HIV infection
    2. 5.3.2 Herpesvirus infections
    3. 5.3.3 Viral hepatitis
    4. 5.3.4 Influenza
    5. 5.3.5 Respiratory syncytial virus
  4. 5.4.0 Antiprotozoal drugs
    1. 5.4.1 Antimalarials
    2. 5.4.2 Amoebicides
    3. 5.4.3 Trichomonacides
    4. 5.4.4 Antigiardial drugs
    5. 5.4.5 Leishmaniacides
    6. 5.4.6 Trypanocides
    7. 5.4.7 Drugs for toxoplasmosis
    8. 5.4.8 Drugs for pneumocystis pneumonia
  5. 5.5.0 Anthelmintics
    1. 5.5.1 Drugs for threadworms
    2. 5.5.2 Ascaricides
    3. 5.5.3 Drugs for tapeworm infections
    4. 5.5.4 Drugs for hookworms
    5. 5.5.5 Schistosomicides
    6. 5.5.6 Filaricides
    7. 5.5.7 Drugs for cutaneous larva migrans
    8. 5.5.8 Drugs for strongyloidiasis
6. Endocrine system
  1. 6.1.0 Drugs used in diabetes
    1. 6.1.1 Insulins
    2. 6.1.2 Antidiabetic drugs
    3. 6.1.3 Diabetic ketoacidosis
    4. 6.1.4 Treatment of hypoglycaemia
    5. 6.1.5 Treatment of diabetic nephropathy and neuropathy
    6. 6.1.6 Diagnostic and monitoring devices for diabetes mellitus
  2. 6.2.0 Thyroid and antithyroid drugs
    1. 6.2.1 Thyroid hormones
    2. 6.2.2 Antithyroid drugs
  3. 6.3.0 Corticosteroids
    1. 6.3.1 Replacement therapy
    2. 6.3.2 Glucocorticoid therapy
  4. 6.4.0 Sex hormones
    1. 6.4.1 Female sex hormones and their modulators
    2. 6.4.2 Male sex hormones and antagonists
    3. 6.4.3 Anabolic steroids
  5. 6.5.0 Hypothalamic and pituitary hormones and anti-oestrogens
    1. 6.5.1 Hypothalamic and anterior pituitary hormones and anti-oestrogens
    2. 6.5.2 Posterior pituitary hormones and antagonists
  6. 6.6.0 Drugs affecting bone metabolism
    1. 6.6.1 Calcitonin and parathyroid hormone
    2. 6.6.2 Bisphosphonates and other drugs affecting bone metabolism
  7. 6.7.0 Other endocrine drugs
    1. 6.7.1 Bromocriptine and other dopaminergic drugs
    2. 6.7.2 Drugs affecting gonadotrophins
    3. 6.7.3 Cushing's Syndrome
    4. 6.7.4 Somatomedins
7. Obstetrics, gynaecology, and urinary-tract disorders
  1. 7.1.0 Drugs used in obstetrics
    1. 7.1.1 Prostaglandins and oxytocics
    2. 7.1.2 Mifepristone
    3. 7.1.3 Myometrial relaxants
  2. 7.2.0 Treatment of vaginal and vulval conditions
    1. 7.2.1 Preparations for vaginal and vulval changes
    2. 7.2.2 Vaginal and vulval infections
  3. 7.3.0 Contraceptives
    1. 7.3.1 Combined hormonal contraceptives
    2. 7.3.2 Progestogen-only contraceptives
    3. 7.3.3 Spermicidal contraceptives
    4. 7.3.4 Contraceptive devices
    5. 7.3.5 Emergency contraception
  4. 7.4.0 Drugs for genito-urinary disorders
    1. 7.4.1 Drugs for urinary retention
    2. 7.4.2 Drugs for urinary frequency, enuresis, and incontinence
    3. 7.4.3 Drugs used in urological pain
    4. 7.4.4 Bladder instillations and urological surgery
    5. 7.4.5 Drugs for erectile dysfunction
    6. 7.4.6 Drugs for premature ejaculation
8. Malignant disease and immunosuppression
  1. 8.1.0 Cytotoxic drugs
    1. 8.1.1 Alkylating drugs
    2. 8.1.2 Anthracyclines and other cytotoxic antibiotics
    3. 8.1.3 Antimetabolites
    4. 8.1.4 Vinca alkaloids and etoposide
    5. 8.1.5 Other antineoplastic drugs
  2. 8.2.0 Drugs affecting the immune response
    1. 8.2.1 Antiproliferative immunosuppressants
    2. 8.2.2 Corticosteroids and other immunosuppressants
    3. 8.2.3 Anti-lymphocyte monoclonal antibodies
    4. 8.2.4 Other immunomodulating drugs
  3. 8.3.0 Sex hormones and hormone antagonists in malignant disease
    1. 8.3.1 Oestrogens
    2. 8.3.2 Progestogens
    3. 8.3.3 Androgens
    4. 8.3.4 Hormone antagonists
9. Nutrition and blood
  1. 9.1.0 Anaemias and some other blood disorders
    1. 9.1.1 Iron-deficiency anaemias
    2. 9.1.2 Drugs used in megaloblastic anaemias
    3. 9.1.3 Drugs used in hypoplastic, haemolytic, and renal anaemias
    4. 9.1.4 Drugs used in platelet disorders
    5. 9.1.5 G6PD deficiency
    6. 9.1.6 Drugs used in neutropenia
    7. 9.1.7 Drugs used to mobilise stem cells
  2. 9.2.0 Fluids and electrolytes
    1. 9.2.1 Oral preparations for fluid and electrolyte imbalance
    2. 9.2.2 Parenteral preparations for fluid and electrolyte imbalance
  3. 9.3.0 Intravenous nutrition
  4. 9.4.0 Oral nutrition
    1. 9.4.1 Foods for special diets
    2. 9.4.2 Enteral nutrition
  5. 9.5.0 Minerals
    1. 9.5.1 Calcium and magnesium
    2. 9.5.2 Phosphorus
    3. 9.5.3 Fluoride
    4. 9.5.4 Zinc
    5. 9.5.5 Selenium
  6. 9.6.0 Vitamins
    1. 9.6.1 Vitamin A
    2. 9.6.2 Vitamin B group
    3. 9.6.3 Vitamin C
    4. 9.6.4 Vitamin D
    5. 9.6.5 Vitamin E
    6. 9.6.6 Vitamin K
    7. 9.6.7 Multivitamin preparations
  7. 9.7.0 Bitters and tonics
  8. 9.8.0 Metabolic disorders
    1. 9.8.1 Drugs used in metabolic disorders
    2. 9.8.2 Acute porphyrias
10. Musculoskeletal and joint diseases
  1. 10.1.0 Drugs used in rheumatic diseases and gout
    1. 10.1.1 Non-steroidal anti-inflammatory drugs
    2. 10.1.2 Corticosteroids
    3. 10.1.3 Drugs that suppress the rheumatic disease process
    4. 10.1.4 Gout and cytotoxic-induced hyperuricaemia
    5. 10.1.5 Other drugs for rheumatic diseases
  2. 10.2.0 Drugs used in neuromuscular disorders
    1. 10.2.1 Drugs that enhance neuromuscular transmission
    2. 10.2.2 Skeletal muscle relaxants
    3. 10.2.3 Drugs used in muscular dystrophy
  3. 10.3.0 Drugs for the treatment of soft-tissue disorders and topical pain relief
    1. 10.3.1 Enzymes
    2. 10.3.2 Rubefacients, topical NSAIDs, capsaicin, and poultices
11. Eye
  1. 11.1.0 Administration of drugs to the eye
  2. 11.2.0 Control of microbial contamination
  3. 11.3.0 Anti-infective eye preparations
    1. 11.3.1 Antibacterials
    2. 11.3.2 Antifungals
    3. 11.3.3 Antivirals
  4. 11.4.0 Corticosteroids and other anti-inflammatory preparations
    1. 11.4.1 Corticosteroids
    2. 11.4.2 Other anti-inflammatory preparations
  5. 11.5.0 Mydriatics and cycloplegics
  6. 11.6.0 Treatment of glaucoma
  7. 11.7.0 Local anaesthetics
  8. 11.8.0 Miscellaneous ophthalmic preparations
    1. 11.8.1 Tear deficiency, ocular lubricants, and astringents
    2. 11.8.2 Ocular diagnostic and peri-operative preparations and photodynamic treatment
    3. 11.8.3 Ocular preparations used in metabolic conditions
  9. 11.9.0 Contact lenses
12. Ear, nose, and oropharynx
  1. 12.1.0 Drugs acting on the ear
    1. 12.1.1 Otitis externa
    2. 12.1.2 Otitis media
    3. 12.1.3 Removal of earwax
  2. 12.2.0 Drugs acting on the nose
    1. 12.2.1 Drugs used in nasal allergy
    2. 12.2.2 Topical nasal decongestants
    3. 12.2.3 Nasal preparations for infection
  3. 12.3.0 Drugs acting on the oropharynx
    1. 12.3.1 Drugs for oral ulceration and inflammation
    2. 12.3.2 Oropharyngeal anti-infective drugs
    3. 12.3.3 Lozenges and sprays
    4. 12.3.4 Mouthwashes, gargles, and dentifrices
    5. 12.3.5 Treatment of dry mouth
13. Skin
  1. 13.1.0 Management of skin conditions
    1. 13.1.1 Vehicles
    2. 13.1.2 Suitable quantities for prescribing
    3. 13.1.3 Excipients and sensitisation
  2. 13.2.0 Emollient and barrier preparations
    1. 13.2.1 Emollients
    2. 13.2.2 Barrier preparations
  3. 13.3.0 Topical local anaesthetics and antipruritics
  4. 13.4.0 Topical corticosteroids
  5. 13.5.0 Preparations for eczema and psoriasis
    1. 13.5.1 Preparations for eczema
    2. 13.5.2 Preparations for psoriasis
    3. 13.5.3 Drugs affecting the immune response
  6. 13.6.0 Acne and rosacea
    1. 13.6.1 Topical preparations for acne
    2. 13.6.2 Oral preparations for acne
    3. 13.6.3 Topical preparations for rosacea
  7. 13.7.0 Preparations for warts and calluses
  8. 13.8.0 Sunscreens and camouflagers
    1. 13.8.1 Sunscreen preparations
    2. 13.8.2 Camouflagers
  9. 13.9.0 Shampoos and other preparations for scalp and hair conditions
  10. 13.10.0 Anti-infective skin preparations
    1. 13.10.1 Antibacterial preparations
    2. 13.10.2 Antifungal preparations
    3. 13.10.3 Antiviral preparations
    4. 13.10.4 Parasiticidal preparations
    5. 13.10.5 Preparations for minor cuts and abrasions
  11. 13.11.0 Skin cleansers, antiseptics, and desloughing agents
    1. 13.11.1 Alcohols and saline
    2. 13.11.2 Chlorhexidine salts
    3. 13.11.3 Cationic surfactants and soaps
    4. 13.11.4 Iodine
    5. 13.11.5 Phenolics
    6. 13.11.6 Oxidisers and dyes
    7. 13.11.7 Desloughing agents
  12. 13.12.0 Hyperhidrosis
  13. 13.13.0 Topical circulatory preparations
14. Immunological products and vaccines
  1. 14.1.0 Active immunity
  2. 14.2.0 Passive immunity
  3. 14.3.0 Storage and use
  4. 14.4.0 Vaccines and antisera
  5. 14.5.0 Immunoglobulins
    1. 14.5.1 Normal immunoglobulin
    2. 14.5.2 Disease-specific immunoglobulins
    3. 14.5.3 Anti-D (Rh0) immunoglobulin
  6. 14.6.0 International travel
15. Anaesthesia
  1. 15.1.0 General anaesthesia
    1. 15.1.1 Intravenous anaesthetics
    2. 15.1.2 Inhalational anaesthetics
    3. 15.1.3 Antimuscarinic drugs
    4. 15.1.4 Sedative and analgesic peri-operative drugs
    5. 15.1.5 Neuromuscular blocking drugs
    6. 15.1.6 Drugs for reversal of neuromuscular blockade
    7. 15.1.7 Antagonists for central and respiratory depression
    8. 15.1.8 Drugs for malignant hyperthermia
  2. 15.2.0 Local anaesthesia
A2. Borderline substances
  1. A2.1.0 Enteral feeds (non-disease specific)
    1. A2.1.1 Enteral feeds (non-disease specific): less than 5 g protein/100 mL
    2. A2.1.2 Enteral feeds (non-disease specific): 5 g (or more) protein/100 mL
    3. A2.1.3 Enteral feeds (non-disease specific): Child under 12 years
  2. A2.2.0 Nutritional supplements (non-disease specific)
    1. A2.2.1 Nutritional supplements: less than 5 g protein/100 mL
    2. A2.2.2 Nutritional supplements: 5 g (or more) protein/100 mL
  3. A2.3.0 Specialised formulas
    1. A2.3.1 Specialised formulas: Infant and child
    2. A2.3.2 Specialised formulas for specific clinical conditions
  4. A2.4.0 Feed supplements
    1. A2.4.1 High-energy supplements
    2. A2.4.2 Fibre, vitamin, and mineral supplements
  5. A2.5.0 Feed additives
    1. A2.5.1 Special additives for conditions of intolerance
    2. A2.5.2 Feed thickeners and pre-thickened drinks
    3. A2.5.3 Flavouring preparations
  6. A2.6.0 Foods for special diets
    1. A2.6.1 Gluten-free foods
    2. A2.6.2 Low-protein foods
  7. A2.7.0 Nutritional supplements for metabolic diseases
A5. Wound management products and elasticated garments
  1. A5.1.0 Basic wound contact dressings
    1. A5.1.1 Low adherence dressings
    2. A5.1.2 Absorbent dressings
  2. A5.2.0 Advanced wound dressings
    1. A5.2.1 Hydrogel dressings
    2. A5.2.2 Vapour-permeable films and membranes
    3. A5.2.3 Soft polymer dressings
    4. A5.2.4 Hydrocolloid dressings
    5. A5.2.5 Foam dressings
    6. A5.2.6 Alginate dressings
    7. A5.2.7 Capillary-action dressings
    8. A5.2.8 Odour absorbent dressings
  3. A5.3.0 Antimicrobial dressings
    1. A5.3.1 Honey
    2. A5.3.2 Iodine
    3. A5.3.3 Silver
    4. A5.3.4 Other antimicrobials
  4. A5.4.0 Specialised dressings
    1. A5.4.1 Protease-modulating matrix dressings
    2. A5.4.2 Silicone keloid dressings
  5. A5.5.0 Adjunct dressings and appliances
    1. A5.5.1 Surgical absorbents
    2. A5.5.2 Wound drainage pouches
    3. A5.5.3 Physical debridement pads
  6. A5.6.0 Complex adjunct therapies
    1. A5.6.1 Topical negative pressure therapy
  7. A5.7.0 Wound care accessories
    1. A5.7.1 Dressing packs
    2. A5.7.2 Woven and fabric swabs
    3. A5.7.3 Surgical adhesive tapes
    4. A5.7.4 Adhesive dressings
    5. A5.7.5 Skin closure dressings
  8. A5.8.0 Bandages
    1. A5.8.1 Non-extensible bandages
    2. A5.8.2 Light-weight conforming bandages
    3. A5.8.3 Tubular bandages and garments
    4. A5.8.4 Support bandages
    5. A5.8.5 Adhesive bandages
    6. A5.8.6 Cohesive bandages
    7. A5.8.7 Compression bandages
    8. A5.8.8 Multi-layer compression bandaging
    9. A5.8.9 Medicated bandages
  9. A5.9.0 Compression hosiery and garments
    1. A5.9.1 Graduated compression hosiery
    2. A5.9.2 Lymphoedema garments